Cykinso
Direct-to-consumer tests for intestinal microbiome profiling. Its flagship product Mykinso uses next-generation sequencing and proprietary bioinformatics for metagenomic profiling of the customer's stool sample. Users can purchase the fecal sample kit, register it online and mail the sample to the company. In addition, they are encouraged to fill in a lifestyle-related questionnaire that Cykinso plans to use in…
Funding snapshot
About
Direct-to-consumer tests for intestinal microbiome profiling. Its flagship product Mykinso uses next-generation sequencing and proprietary bioinformatics for metagenomic profiling of the customer's stool sample. Users can purchase the fecal sample kit, register it online and mail the sample to the company. In addition, they are encouraged to fill in a lifestyle-related questionnaire that Cykinso plans to use in future research. Results can be viewed on the company website or the accompanying app Founded in 2014, headquartered in Shibuya, Japan. The company has raised $15.7M at the Series D stage backed by investors including Nitto Boseki, Nihonkai, REVIC, Innoh Associates, Yamanashi Chugin Management Consulting. Operating in Life Sciences > Genomics, Life Sciences > Clinical Genomics.
Business model
Genomics > Applied Genomics > Consumer Genomics > Microbiomics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.